|Articles|April 8, 2019
Utilizing an Integrated, Multi-Channel Approach Can Improve Access for Oncology Products
Author(s)McKesson Life Sciences
How biopharma companies can pursue multiple channels to enhance access to segmented markets.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff
2
President Trump Planning to Fire FDA Commissioner Marty Makary: Report
3
Marty Makary Out as FDA Commissioner: Report
4
From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box
5